Angiotensin-Converting Enzyme Inhibitor-Induced Angioedema

被引：0
|
作者：
Theyab, Abduljabar A. [1 ]
Lee, David S. [2 ]
Khachemoune, Amor [3 ]
机构：
[1] Al Anbar Univ, Ramadi Coll Med, Al Anbar, Iraq
[2] Los Angeles Cty Univ So Calif Med Ctr, Dept Dermatol, Los Angeles, CA USA
[3] VA NY Harbor Healthcare Syst, Dermatol Serv, Brooklyn, NY 11203 USA
来源：
CUTIS | 2013年 / 91卷 / 01期
关键词：
HEREDITARY ANGIOEDEMA; ACE-INHIBITOR; SUBSTANCE-P; VISCERAL ANGIOEDEMA; CARBOXYPEPTIDASE-N; THERAPY; EDEMA; POTENTIATION; BRADYKININ; EMERGENCY;
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
Angiotensin-converting enzyme (ACE) inhibitors frequently are prescribed for the management of cardiovascular disorders. In addition to their therapeutic potential, ACE inhibitors are associated with numerous adverse effects, some of which may be lethal. Angioedema is an uncommon but serious acute event that may affect any individual taking an ACE inhibitor. This review outlines the advances in our understanding of the pathogenesis, clinical presentation, and management of this medical emergency. Cutis. 2013;91:30-35.
引用
收藏
页码：30 / 35
页数：6
相关论文
共 50 条
  • [1] Angiotensin-Converting Enzyme Inhibitor-Induced Angioedema
    Wilkerson, R. Gentry
    Winters, Michael E.
    EMERGENCY MEDICINE CLINICS OF NORTH AMERICA, 2022, 40 (01) : 79 - 98
  • [2] Angiotensin-Converting Enzyme Inhibitor-Induced Angioedema
    Wilkerson, R. Gentry
    Winters, Michael E.
    IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA, 2023, 43 (03) : 513 - 532
  • [3] Angiotensin-converting Enzyme Inhibitor-induced Angioedema
    Bezalel, Shira
    Mahlab-Guri, Keren
    Asher, Ilan
    Werner, Ben
    Sthoeger, Zev Moshe
    AMERICAN JOURNAL OF MEDICINE, 2015, 128 (02): : 120 - 125
  • [4] Pharmacogenetics of angiotensin-converting enzyme inhibitor-induced angioedema
    Pall, Amalie Hartvig
    Rasmussen, Eva Rye
    Wadelius, Mia
    PHARMACOGENOMICS, 2021, 22 (06)
  • [5] Pharmacogenetics of angiotensin-converting enzyme inhibitor-induced angioedema
    Liau, Yusmiati
    Chua, Ignatius
    Kennedy, Martin A.
    Maggo, Simran
    CLINICAL AND EXPERIMENTAL ALLERGY, 2019, 49 (02): : 142 - 154
  • [6] Management of Angiotensin-Converting Enzyme Inhibitor-Induced Angioedema
    Al-Khudari, Samer
    Loochtan, Michael J.
    Peterson, Edward
    Yaremchuk, Kathleen L.
    LARYNGOSCOPE, 2011, 121 (11): : 2327 - 2334
  • [7] Angiotensin-converting enzyme inhibitor-induced visceral angioedema
    Marmery, H.
    Mirvis, S. E.
    CLINICAL RADIOLOGY, 2006, 61 (11) : 979 - 982
  • [8] Icatibant Use in Angiotensin-Converting Enzyme Inhibitor-Induced Angioedema
    Egan, Maureen
    Wang, Julie
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2015, 3 (05): : 824 - 825
  • [9] ANGIOTENSIN-CONVERTING ENZYME INHIBITOR-INDUCED ANGIOEDEMA - STILL UNRECOGNIZED
    FINLEY, CJ
    SILVERMAN, MA
    NUNEZ, AE
    AMERICAN JOURNAL OF EMERGENCY MEDICINE, 1992, 10 (06): : 550 - 552
  • [10] Clinical experience with angiotensin-converting enzyme inhibitor-induced angioedema
    Grant, Nazaneen N.
    Deeb, Ziad E.
    Chia, Stanley H.
    OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2007, 137 (06) : 931 - 935
12345